Australian life sciences sector unites in opposition to proposed R&D Tax Incentive changes

BioMelbourne Network, along with AusBiotech and seven other of Australia’s leading biotech, medtech and health tec...

June 11, 2026 | Thursday | News
NUS Medicine launches neuroscience translational research programme

The Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) has established a new Neurosc...

June 10, 2026 | Wednesday | News
NUS Medicine and PolyU ink MoU to advance AI-enabled musculoskeletal research

The Department of Orthopaedic Surgery at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medi...

June 9, 2026 | Tuesday | News
Singapore develops new fluorescent nanosensor for gut health biomarker detection

Researchers from the National Institute of Education, Nanyang Technological University, Singapore (NIE NTU, Singapore)...

June 8, 2026 | Monday | News
FDA Approves Genentech’s Tecentriq for ctDNA-Guided Adjuvant Bladder Cancer Treatment

Genentech has received US FDA approval for Tecentriq and Tecentriq Hybreza as adjuvant treatment for adults with muscle-...

June 8, 2026 | Monday | News
Hansa Biopharma Reports Positive European Post-Authorisation Data for Idefirix

Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...

June 8, 2026 | Monday | News
Chinese biotech startup LongBio Pharma lists on Hong Kong Stock Exchange

LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and ...

June 8, 2026 | Monday | News
FDA Approves TREMFYA Label Expansion for Structural Joint Damage in Psoriatic Arthritis

Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...

June 5, 2026 | Friday | News
Amgen Receives EC Approval for IMDYLLTRA in Extensive-Stage Small Cell Lung Cancer

Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...

June 5, 2026 | Friday | News
MAVERIC launches to accelerate next generation of Australian research

Monash University’s AI supercomputer MAVERIC is officially launched, with researchers already using its advanced c...

June 5, 2026 | Friday | News
Gelteq establishes Centre of Excellence in China to accelerate product development

Australia-based Gelteq has announced the establishment of a new Gelteq Centre of Excellence in Guangdong Province, China...

June 5, 2026 | Friday | News
Vertex’s Povetacicept BLA Accepted by US FDA for IgA Nephropathy

Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...

June 4, 2026 | Thursday | News
Henlius and Organon Secure EC Approval for First Pertuzumab Biosimilar in Europe

Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...

June 4, 2026 | Thursday | News
Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6

Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...

June 4, 2026 | Thursday | News
Medable Launches Agentic Accelerator Program to Help Life Sciences Companies Deploy Agentic AI Across Clinical Lifecycle

Medable Inc., the leading technology platform for agentic AI-powered clinical development, today announced its Agentic A...

June 4, 2026 | Thursday | News
Everest Medicines signs $1 B deal with Travere Therapeutics for rare kidney diseases treatment

China-based Everest Medicines has entered into an exclusive licensing and collaboration agreement with US-based Travere ...

June 4, 2026 | Thursday | News
FunPep and Crafton Biotech enter into joint research agreement for therapeutic mRNA vaccines in Japan

Japan-based FunPep and Crafton Biotechnology have entered into a joint research agreement and commenced collaborative re...

June 5, 2026 | Friday | News
South Korea to cut new drug approval reviews to 240 days

The Ministry of Food and Drug Safety (MFDS) in South Korea has established the "Medical Product Approval and Review...

June 4, 2026 | Thursday | News
M42 and Arcera partner to advance biopharma localisation and next-gen life sciences in Abu Dhabi

M42, a global health leader powered by technology, artificial intelligence, and genomics, and Arcera Life Sciences, a gl...

June 3, 2026 | Wednesday | News
Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate Drug Discovery

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the Thermo Scientific Orbitrap...

June 3, 2026 | Wednesday | News
Temasek Life Sciences Laboratory highlights research-driven approach to mosquito-borne disease control in Asia

Temasek Life Sciences Laboratory has highlighted the importance of life sciences research in strengthening Asia’s ...

June 3, 2026 | Wednesday | News
China's Haisco Pharma inks $2.9 B deal with Eli Lilly focusing on multiple therapeutic areas

China-based Haisco Pharmaceutical Group has announced a licensing and research collaboration with American firm Eli Lill...

June 3, 2026 | Wednesday | News
Japanese dental startup Toregem raises $5.3 M to treat congenital tooth agenesis

Japan-based startup Toregem BioPharma has raised approximately $5.3 million (JPY 850 million) in Pre-Series C financing ...

June 2, 2026 | Tuesday | News
Biond Biologics and Guangzhou-Israel Biotechnology Fund invest $8 M to advance oncology programmes in China

Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cance...

June 2, 2026 | Tuesday | News
Australia leads first-in-human trial of cholesterol-lowering genetic therapy

The Victorian Heart Hospital and the Victorian Heart Institute will lead a first-in-human clinical trial of a new invest...

May 29, 2026 | Friday | News